Results 271 to 280 of about 82,606 (343)

Psychological stress catalyses free radical–mediated activation of coagulation in humans

open access: yesThe Journal of Physiology, EarlyView.
Abstract figure legend This study provides the first in vivo evidence that acute psychological stress triggers systemic free radical formation and prothrombotic remodelling of blood clot microstructure. By inducing stress in healthy participants, we observed a significant increase in oxidative stress (A•−), a shortening of the intrinsic pathway of ...
Lewis Fall   +11 more
wiley   +1 more source

Pancreas, Muscle, and Subcutaneous Fat Atrophy in Patients Undergoing Radiation for Neuroblastoma

open access: yesPediatric Blood &Cancer, Volume 73, Issue 6, June 2026.
ABSTRACT Background/Objectives Radiation therapy (RT) is part of standard‐of‐care therapy in high‐risk neuroblastoma (HR‐NBL) but can significantly affect nearby tissue. The objectives of this study were (1) to characterize changes in pancreas volume after RT and (2) to characterize changes in body composition, including body weight percentile ...
Pradipta Debnath   +10 more
wiley   +1 more source

Cardiovascular β‐Adrenergic Receptor Distribution and Function: Influence of Species, Sex, Age, and Tissue

open access: yesComprehensive Physiology, Volume 16, Issue 3, June 2026.
Estrogen modulates β‐AR signaling in a context‐dependent manner influenced by species, sex, age, tissue, and vascular health, highlighting challenges in translating findings from experimental models to human cardiovascular physiology. ABSTRACT Cardiovascular diseases remain the leading global cause of morbidity and mortality, with notable sex‐specific ...
Basant Elsaid   +5 more
wiley   +1 more source

Adrenal insufficiency in giant cell arteritis. [PDF]

open access: yesRheumatol Adv Pract
Ducker G, Dhatariya K, Mukhtyar CB.
europepmc   +1 more source

Impact of Frequent Immune‐Mediated Adverse Events on Treatment Continuity and Outcomes During Durvalumab Plus Tremelimumab Therapy for Unresectable Hepatocellular Carcinoma

open access: yesLiver International Communications, Volume 7, Issue 2, June 2026.
ABSTRACT Durvalumab plus tremelimumab (Dur/Tre) is the first‐line treatment for unresectable hepatocellular carcinoma (uHCC). Immune‐mediated adverse events (imAEs) are common; however, the impact of specific imAE types on treatment persistence and outcomes remains unclear.
Tomomitsu Matono   +53 more
wiley   +1 more source

Management of neonatal massive hemorrhage: A narrative review

open access: yes
Transfusion, EarlyView.
Cheryl S. L. Chooi   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy